Michael Fiore compensation by year
HEALTHEQUITY Summary Compensation Table · all 2 fiscal years held| Component | FY2025 | FY2026 |
|---|---|---|
| Salary | $470,355 | $550,000 |
| Bonus | $0 | $0 |
| Stock awards | $6,479,118 | $3,217,217 |
| Option awards | $0 | $0 |
| Non-equity incentive | $435,666 | $408,375 |
| Pension and deferred compensation | $0 | $0 |
| All other | $16,180 | $4,812 |
| Total | $7,401,319 | $4,180,404 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HEALTHEQUITY, INC. DEF 14A filed May 13, 2026, accession 0001428336-26-000022, and prior-year filings.
How this page was built: the HEALTHEQUITY, INC. filed document, accession 0001428336-26-000022. Every figure is read from that document and cited to the page and table it appears in. Filed May 13, 2026.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 30,870 | $2,644,633 | — |
| PSU | 30,184 | $1,847,045 | — |
| PSU | 15,495 | $1,327,457 | — |
| RSU | 15,495 | $1,327,457 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in HEALTHEQUITY, INC.'s FY2026 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments HEALTHEQUITY discloses, by trigger · FY2026| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Disability | $0 | $0 | $0 | $408,375 |
| Resignation for good reason, no change in control | $550,000 | $0 | $36,081 | $994,456 |
| Change in control and resignation for good reason | $550,000 | $6,828,756 | $36,081 | $7,823,212 |
| Death | $0 | $0 | $0 | $408,375 |
| Change in control and involuntary termination | $550,000 | $6,828,756 | $36,081 | $7,823,212 |
| Involuntary termination without cause | $550,000 | $0 | $36,081 | $994,456 |
Per the Potential Payments Upon Termination or Change in Control table in HEALTHEQUITY, INC.'s FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.
HEALTHEQUITY’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Scott Cutler | President and Chief Executive Officer | $13,582,105 |
| James Lucania | Executive Vice President and Chief Financial Officer | $5,156,388 |
| Elimelech Rosner | Former Executive Vice President and Chief Technology Officer | $4,521,528 |
| Michael Fiore · this page | Executive Vice President and Chief Commercial Officer | $4,180,404 |
| Delano Ladd | Executive Vice President and General Counsel | $3,634,598 |
| Stephen Neeleman | Founder and Vice Chairman | $3,499,924 |
The full HEALTHEQUITY compensation record
free company briefThis page is one person within HEALTHEQUITY's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the HEALTHEQUITY proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order HEALTHEQUITY's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HEALTHEQUITY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.